Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease


Evidence of the potential benefits of long-term oral branched-chain amino acid (BCAA) supplementation in reducing the severity of liver disease is limited.Patients who were diagnosed with liver cirrhosis with a Child-Pugh (CP) score of 8-10 were included. The BCAA group consumed BCAAs daily for at least 6 months, and the control group consumed a diet… (More)
DOI: 10.1097/MD.0000000000006580


8 Figures and Tables